Latest news
Alzamend Neuro (ALZN) Drops 3.5% to $1.38 as Shares Approach Key Support - Hagopian Line - dars.gov.etdars.gov.et · Fri, 07 Aug 2026 02:44:48 GMTAlzamend’s $7.5M Funding Will Continue Alzheimer’s Vaccine Trial - Stock TitanStock Titan · Tue, 04 Aug 2026 12:00:00 GMTAlzamend Neuro Received Notice of Noncompliance - TradingViewTradingView · Mon, 03 Aug 2026 20:33:00 GMTAlzamend Neuro Secures Up to $25 Million Series D Preferred Financing; $7.5 Million Funded - TradingViewTradingView · Mon, 03 Aug 2026 20:33:00 GMTALZN 8-K & SEC Filings - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 07:00:00 GMTYou were invited to TradingView - TradingViewTradingView · Sun, 02 Aug 2026 02:19:10 GMT